Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
BACKGROUND: Although clozapine has been shown to be the treatment of choice in people with schizophrenia that are resistant to treatment, one third to two thirds of people still have persistent positive symptoms despite clozapine monotherapy of adequate dosage and duration. The need to provide effec...
主要な著者: | Cipriani, A, Boso, M, Barbui, C |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2009
|
類似資料
-
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
著者:: Barber, S, 等
出版事項: (2017) -
Does the addition of a second antipsychotic drug improve clozapine treatment?
著者:: Barbui, C, 等
出版事項: (2009) -
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
著者:: Cipriani, A, 等
出版事項: (2013) -
Retrospective evaluation of sociodemographic and clinical characteristics of patients with schizophrenia receiving clozapine monotherapy and clozapine combined with different antipsychotics
著者:: E. Yıldız, 等
出版事項: (2024-04-01) -
Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
著者:: Jari Tiihonen, 等
出版事項: (2012-01-01)